glioblastoma

Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy
Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy
Fierce Biotech
Ziopharm Oncology
IL-12
gene therapy
glioblastoma
clinical trials
Flag link:
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Pharmaforum
Karyopharm
Xpovio
brain cancer
Selinexor
clinical trials
glioblastoma
Flag link:
AbbVie stock down 1.8% in premarket trade after failure of glioblastoma drug trial
AbbVie stock down 1.8% in premarket trade after failure of glioblastoma drug trial
Marketwatch
AbbVie
Depatux-M
glioblastoma
cilnical trials
Flag link:
Inovio Closes Enrollment in Brain Cancer Study Before Time
Inovio Closes Enrollment in Brain Cancer Study Before Time
Yahoo/Zacks.com
Inovio
clinical trials
INO-5401
INO-9012
Libtayo
glioblastoma
Flag link:
First Patient Treated Under Right to Try Law
First Patient Treated Under Right to Try Law
RAPS.org
glioblastoma
right to try
ERC-1671
ERC
Flag link:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
CP Wire
Bayer
regorafenib
glioblastoma
Flag link:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer
regorafenib
glioblastoma
Flag link:
Two papers open door to T cell brain entry for glioblastoma therapy
Two papers open door to T cell brain entry for glioblastoma therapy
BioCentury
T-cells
glioblastoma
brain cancer
Nature
Flag link:
Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains
Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains
Fierce Biotech
polio
glioblastoma
Duke University
Flag link:
Why ZIOPHARM Oncology, Inc. Stock Broke Out in May
Why ZIOPHARM Oncology, Inc. Stock Broke Out in May
Motley Fool
Ziopharma
right-to-try laws
Ad-RTS-hIL-12
glioblastoma
Flag link:
Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster
Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster
Fierce Biotech
Northwest Biotherapeutics
vaccines
dendritic cell vaccines
clinical trials
glioblastoma
Flag link:
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Endpoints
clinical trials
VBL Therapeutics
VB-111
Roche
Avastin
glioblastoma
Flag link:
The Fastest Growing Cancer Company You've Never Heard Of
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
Flag link:
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Endpoints
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Flag link:
FDA Allows Ziopharm Brain Cancer Drug Trial
FDA Allows Ziopharm Brain Cancer Drug Trial
Investopedia
FDA
Ziopharm
brain cancer
clinical trials
Ad-RTS-hIL-12
glioblastoma
Flag link:
CAR-T therapy makes early inroads in treating brain cancer
CAR-T therapy makes early inroads in treating brain cancer
Stat
CAR-T
glioblastoma
brain cancer
Flag link:
Celgene CEO: myeloma and glioblastoma both priorities
Celgene CEO: myeloma and glioblastoma both priorities
BioPharma Dive
Celgene
Multiple Myeloma
glioblastoma
marizomib
R&D
Flag link:
3 Shocking Biotech Flops of 2016 So Far
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
Flag link:
AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting
AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting
Yahoo
AbbVie
glioblastoma
brain cancer
ASCO 2016
ABT-414
Flag link:
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
phys.org
TH-302
Threshold Pharmaceuticals
glioblastoma
brain cancer
Flag link:

Pages